Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer’s disease and Parkinson’s disease
- 31 August 2000
- journal article
- review article
- Published by Elsevier in Behavioural Brain Research
- Vol. 113 (1-2) , 121-129
- https://doi.org/10.1016/s0166-4328(00)00207-2
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1998
- Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in ratsNeuroscience, 1997
- Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's DiseaseCNS Drug Reviews, 1995
- Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21Brain Research, 1995
- Nicotine may relieve symptoms of Parkinson's diseasePsychopharmacology, 1994
- Effects of post-learning smoking on memory consolidationPsychopharmacology, 1992
- Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's DiseasesJournal of Neurochemistry, 1992
- Cholinergic deficiency and frontal dysfunction in Parkinson's diseaseAnnals of Neurology, 1990
- Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human BrainJournal of Neurochemistry, 1988
- Cholinergic‐dependent cognitive deficits in Parkinson's diseaseAnnals of Neurology, 1987